In critical conditions, such as sepsis, COVID-19 and non-COVID-19 acute respiratory failure (ARF) and extensive trauma, fibrinolysis resistance has been associated with elevated levels of plasminogen activator inhibitor-1 (PAI-1) [6–8, 11–13]. This evidence concerns the gene SERPINE1 and COVID-19.